MBIO
Mustang Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.54
−3.88%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-19.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 27, 2026 | Litchman Manuel MD · director, officer: President, CEO and Interim CFO | F-InKind | 19 | $0.75 |
| Jan 5, 2026 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 278,385 | $0.00 |
| Dec 30, 2025 | Chill Adam J. · director | Sale | 4 | $0.95 |
| Dec 30, 2025 | Jin David · director | Purchase | 247 | $0.96 |
| Dec 30, 2025 | Herskowitz Neil · director | Sale | 247 | $0.96 |
| Oct 1, 2025 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 59,334 | $0.00 |
| Apr 28, 2025 | Litchman Manuel MD · director, officer: President, CEO and Interim CFO | F-InKind | 27 | $1.24 |
| Apr 2, 2025 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 67,806 | $0.00 |
| Jun 28, 2024 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 575,191 | $0.00 |
| Jun 4, 2024 | Litchman Manuel MD · director, officer: President and CEO | F-InKind | 1,248 | $12 |
| Jun 4, 2024 | Litchman Manuel MD · director, officer: President and CEO | F-InKind | 1,572 | $4.21 |
| Jun 4, 2024 | Litchman Manuel MD · director, officer: President and CEO | F-InKind | 1,396 | $0.35 |
| Jan 3, 2024 | Fortress Biotech, Inc. · 10 percent owner | A-Award | 419,092 | $0.00 |
| Jul 7, 2023 | Chill Adam J. · director | A-Award | 7,246 | $0.00 |
| Jul 7, 2023 | ROSENWALD LINDSAY A MD · director | A-Award | 7,246 | $0.00 |
| Jul 7, 2023 | ZELEFSKY MICHAEL J · director | A-Award | 7,246 | $0.00 |
| Jul 7, 2023 | Herskowitz Neil · director | A-Award | 7,246 | $0.00 |
| Jul 7, 2023 | Litchman Manuel MD · director, officer: President and CEO | A-Award | 5,000 | $0.00 |
| Jul 7, 2023 | WEISS MICHAEL S · director | A-Award | 7,246 | $0.00 |
| Apr 3, 2023 | Litchman Manuel MD · director | A-Award | 61,000 | $0.00 |
| Apr 3, 2023 | Litchman Manuel MD · director | Purchase | 5,000 | $0.52 |
| Apr 3, 2023 | ROSENWALD LINDSAY A MD · director | Purchase | 5,000 | $0.52 |
| Apr 3, 2023 | ROSENWALD LINDSAY A MD · director | A-Award | 71,664 | $0.00 |
| Apr 3, 2023 | ROSENWALD LINDSAY A MD · director | Purchase | 4,094 | $0.74 |
| Apr 3, 2023 | Herskowitz Neil · director | A-Award | 71,664 | $0.00 |
| Apr 3, 2023 | ZELEFSKY MICHAEL J · director | A-Award | 71,664 | $0.00 |
| Apr 3, 2023 | Chill Adam J. · director | A-Award | 71,664 | $0.00 |
| Apr 3, 2023 | WEISS MICHAEL S · director | A-Award | 71,664 | $0.00 |
| Jan 6, 2023 | Fortress Biotech, Inc. · director | A-Award | 2,807,008 | $0.00 |
| Dec 16, 2021 | Achenbach Brian · officer: SVP, Fin. & Corp. Controller | Sale | 4,374 | $1.83 |
Institutional positioning
13F filings over the trailing two quarters
New 9Increased 9Reduced 5Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Kestra Advisory Services, LLC | Increased | 196,991 | Jul 28, 2026 |
| KESTRA ADVISORY SERVICES, LLC | Increased | 176,042 | Apr 30, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 92,790 | May 15, 2026 |
| BlackRock, Inc. | Unchanged | 84,745 | Aug 7, 2026 |
| BLACKROCK, INC. | Unchanged | 84,745 | May 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 59,459 | Sep 2, 2026 |
| CITADEL ADVISORS LLC | Reduced | 53,200 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 42,240 | Aug 12, 2026 |
| CFO4Life Group, LLC | Increased | 33,510 | Aug 12, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 32,120 | May 8, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 32,120 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 25,704 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Unchanged | 25,704 | Aug 13, 2026 |
| CFO4LIFE GROUP, LLC | Increased | 20,461 | May 11, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 16,754 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 27, 2026